Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have earned an average recommendation of "Hold" from the eight analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, one has given a buy rating and two have given a strong buy rating to the company.

RHHBY has been the subject of several recent analyst reports. UBS Group raised Roche from a "hold" rating to a "strong-buy" rating in a report on Thursday, February 13th. Morgan Stanley initiated coverage on Roche in a report on Wednesday, February 12th. They issued an "equal weight" rating for the company. Hsbc Global Res downgraded Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. Sanford C. Bernstein raised Roche to a "strong-buy" rating in a report on Thursday, January 30th. Finally, HSBC downgraded Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th.

Roche Trading Down 0.8%

OTCMKTS:RHHBY opened at $39.08 on Friday. Roche has a twelve month low of $31.19 and a twelve month high of $44.31. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86. The business has a 50 day moving average price of $39.71 and a two-hundred day moving average price of $38.60.

Institutional Investors Weigh In On Roche

A number of large investors have recently added to or reduced their stakes in RHHBY. Hantz Financial Services Inc. raised its stake in Roche by 0.9% in the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company's stock valued at $1,176,000 after acquiring an additional 305 shares during the period. Verity Asset Management Inc. increased its position in Roche by 26.8% during the 4th quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock worth $280,000 after buying an additional 1,697 shares during the period. Altrius Capital Management Inc increased its position in Roche by 0.3% during the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company's stock worth $6,399,000 after buying an additional 603 shares during the period. SVB Wealth LLC bought a new position in Roche during the 4th quarter worth $555,000. Finally, HighPoint Advisor Group LLC increased its position in Roche by 2.8% during the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after buying an additional 304 shares during the period.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.